According to the results above, we can speculate that higher expression levels of NXPH4 may be closely related to worse survival outcomes (overall survival, disease-specific survival, progress-free interval) for patients with bladder cancer. This evidence concerns the gene NXPH4 and urinary bladder carcinoma.